Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood

Saved in:
Bibliographic Details
Published in:Cardiovascular drugs and therapy 2015, Vol.29 (5), p.415-418
Main Authors: Bell, R. M., Sivaraman, V., Kunuthur, S. P., Cohen, M. V., Downey, J. M., Yellon, D. M.
Format: Article
Language:English
Subjects:
Adenosine Monophosphate - analogs & derivatives
Adenosine Monophosphate - therapeutic use
Animals
Blood Platelets - drug effects
Blood Platelets - metabolism
Cardiology
Cardiotonic Agents - therapeutic use
Diabetes Complications - blood
Diabetes Complications - prevention & control
Dose-Response Relationship, Drug
Humans
Male
Medicine
Medicine & Public Health
Mice
Myocardial Ischemia - blood
Myocardial Ischemia - complications
Myocardial Ischemia - drug therapy
Myocardial Ischemia - prevention & control
Myocardial Reperfusion Injury - blood
Myocardial Reperfusion Injury - complications
Myocardial Reperfusion Injury - drug therapy
Myocardial Reperfusion Injury - prevention & control
Purinergic P2Y Receptor Antagonists - therapeutic use
Rats
Rats, Inbred Strains
Receptors, Purinergic P2Y12 - metabolism
Short Communication
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0920-3206
1573-7241
DOI:10.1007/s10557-015-6609-2